Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
765
-146
-16% -$232K 0.12% 93
2026
Q1
$1.2M Buy
911
+74
+9% +$101K 0.11% 102
2025
Q4
$895K Buy
837
+20
+2% +$20.9K 0.07% 125
2025
Q3
$791K Sell
817
-4
-0.5% -$3.14K 0.06% 132
2025
Q2
$658K Buy
821
+1
+0.1% +$718 0.06% 150
2025
Q1
$544K Buy
820
+142
+21% +$103K 0.05% 156
2024
Q4
$470K Sell
678
-589
-46% -$423K 0.05% 146
2024
Q3
$878K Buy
1,267
+398
+46% +$356K 0.09% 98
2024
Q2
$888K Buy
869
+831
+2,187% +$799K 0.1% 71
2024
Q1
$36.9K Buy
+38
New +$33.7K 0.01% 301

Other funds holding ASML

LRI Investments's ASML Position: Q2 2026 in Review

LRI Investments reduced its ASML (ASML) stake by 16% in Q2 2026, selling an estimated $232K and leaving 765 shares worth $1.52M. The position accounts for 0.12% of the portfolio, ranked #93.

LRI Investments first reported a position in ASML in Q1 2024 and has held it in 10 quarters since. 1,058 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • LRI Investments held 765 shares of ASML worth $1.52M as of Q2 2026.
  • LRI Investments sold 146 ASML shares in Q2 2026, an estimated $232K.
  • ASML made up 0.12% of LRI Investments's portfolio in Q2 2026, its #93 holding.
  • LRI Investments first reported a position in ASML in Q1 2024 and has held it in 10 quarters since.
  • 1,058 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.